What question did this study set out to answer?

This research aims to evaluate if coronary revascularization guided by late gadolinium enhancement granularity can predict mortality in patients with ischemic cardiomyopathy.

February 2, 2026

Can late gadolinium enhancement location and extent guide coronary revascularisation in ischaemic cardiomyopathy?

Key Points

This research aims to evaluate if coronary revascularization guided by late gadolinium enhancement granularity can predict mortality in patients with ischemic cardiomyopathy.
Conducted a retrospective analysis of patients with ischemic cardiomyopathy referred for CMR viability assessment from 2008 to 2022.
Included patients with left ventricular ejection fraction <50% and viable myocardium.
Collected late gadolinium enhancement parameters and revascularization data within 90 days of CMR analysis.
Used Cox proportional hazards regression to analyze the relationship between LGE granularity, revascularization, and mortality.
1,698 patients were analyzed, with a mean age of 64 years and 74% male.
88% of patients underwent revascularization within 90 days after CMR.
Moderate LGE extent was found in 54% of patients, and antero-septal LGE was present in 19% of patients.
4.7% of patients died over a median follow-up of 8.9 years; revascularization was linked to significantly lower mortality (HR 0.28, p<0.001).

Abstract

Abstract Background The role of cardiovascular magnetic resonance (CMR) in guiding coronary revascularisation based on myocardial viability remains debated, particularly after the REVIVED trial. Our group has recently introduced the concept of "late gadolinium enhancement (LGE) granularity", incorporating LGE extent and location to refine myocardial characterization. OBJECTIVE To assess whether CMR-guided coronary revascularisation, based on the LGE granularity, predicts mortality in patients with ischaemic cardiomyopathy (ICM), reduced left ventricular ejection fraction (LVEF 50%), and viable myocardium (ischaemic-LGE transmurality 50%). Methods We conducted a retrospective analysis of a multicentre study including consecutive ICM patients referred for CMR-based viability assessment between 2008 and 2022. Eligibility criteria included left ventricular ejection fraction (LVEF) 50%, viable myocardium, and at least one of the following: ≥70% stenosis in ≥1 epicardial coronary artery, prior myocardial infarction, or previous coronary revascularization. LGE parameters and revascularization within 90 days of CMR were collected. The primary endpoint was all-cause mortality. Cox proportional hazards regression analysis was performed to assess the predictive value of LGE parameters and revascularization status for all-cause mortality. Results Among 1,698 patients (mean age 64±12 years; 74% male), 1,502 (88%) underwent revascularisation within 90 days. LGE extent was low (1–2 segments) in 729 (43%), moderate (3–5 segments) in 922 (54%), and high (≥6 segments) in 47 (3%). Antero-septal LGE was present in 318 patients (19%) (Figure 1). Over a median follow-up of 8.9 years (IQR 6.7–11.5 years), 79 patients (4.7%) died. In univariate analysis, revascularisation was associated with lower mortality (HR: 0.28, 95% CI: 0.17–0.45, p0.001). Subgroup analyses revealed that revascularisation particularly improved survival in patients with moderate LGE extent (3–5 segments, p=0.002) and antero-septal LGE (p0.001, Figure 2). Conclusion Using the LGE granularity concept, we showed that in ICM patients with viable myocardium, revascularisation was associated with improved survival, particularly in those with moderate ischaemic LGE extent and an antero-septal distribution.LGE granularity Survival curves

AI에게 질문

Bookmark

Cite This Study

Unger et al. (Thu,) studied this question.

synapsesocial.com/papers/6980fe00c1c9540dea80fc0c https://doi.org/https://doi.org/10.1093/ehjci/jeaf367.379

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI에게 질문

Bookmark